This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Hemophilia A
and you are
between 12 and 35
years old
4
The primary goal of this phase is to monitor the long-term effects.
The treatment is already on the market.
Show me locations

The purpose

The joint status (knees, ankles) of patients suffering from severe Hemophilia A (too little blood clotting factor VIII in blood) is evaluated in a single magnetic resonance imaging session. No study medication is given.

Provided treatments

  • Procedure: No Drug
  • Procedure: No Drug
  • Procedure: No Drug
  • Procedure: No Drug
  • Procedure: No Drug
Tris trial is registered with FDA with number: NCT00927667. The sponsor of the trial is Bayer and it is looking for 156 volunteers for the current phase.
Official trial title:
A Diagnostic Interventional, Controlled, Cross-sectional Evaluation of Joint Status Using Magnetic Resonance Imaging in Subjects With Severe Hemophilia A Treated With Primary Prophylaxis, Secondary Prophylaxis, or On-demand Therapy